GAMMA Investing LLC boosted its holdings in shares of NICE Ltd. (NASDAQ:NICE - Free Report) by 2,938.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,488 shares of the technology company's stock after purchasing an additional 12,077 shares during the quarter. GAMMA Investing LLC's holdings in NICE were worth $1,925,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Park Square Financial Group LLC acquired a new stake in NICE during the 4th quarter valued at $25,000. B. Riley Wealth Advisors Inc. lifted its holdings in NICE by 8.3% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 2,058 shares of the technology company's stock worth $350,000 after acquiring an additional 158 shares in the last quarter. Q Global Advisors LLC bought a new stake in shares of NICE in the fourth quarter valued at about $4,597,000. Formidable Asset Management LLC acquired a new stake in shares of NICE in the fourth quarter valued at about $682,000. Finally, Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of NICE in the fourth quarter valued at about $313,808,000. Institutional investors own 63.34% of the company's stock.
Analyst Ratings Changes
Several research firms have issued reports on NICE. Morgan Stanley dropped their price objective on NICE from $235.00 to $202.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. DA Davidson raised their price objective on NICE from $180.00 to $185.00 and gave the company a "buy" rating in a report on Friday, May 16th. Citigroup lowered their target price on NICE from $214.00 to $211.00 and set a "buy" rating for the company in a research report on Monday, May 19th. Barclays reduced their target price on NICE from $286.00 to $226.00 and set an "overweight" rating for the company in a research note on Friday, February 21st. Finally, Wedbush reiterated an "outperform" rating and set a $200.00 price target on shares of NICE in a research note on Friday, May 16th. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $208.92.
View Our Latest Research Report on NICE
NICE Price Performance
Shares of NICE stock opened at $165.68 on Friday. The stock has a market capitalization of $10.48 billion, a price-to-earnings ratio of 24.51, a PEG ratio of 1.07 and a beta of 1.01. NICE Ltd. has a 1 year low of $137.19 and a 1 year high of $200.65. The company's fifty day simple moving average is $160.84 and its two-hundred day simple moving average is $163.78.
NICE (NASDAQ:NICE - Get Free Report) last released its quarterly earnings results on Thursday, May 15th. The technology company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.84 by $0.03. NICE had a net margin of 16.18% and a return on equity of 16.17%. The firm had revenue of $700.19 million for the quarter, compared to analysts' expectations of $699.46 million. During the same quarter in the prior year, the firm posted $2.58 earnings per share. The business's quarterly revenue was up 6.2% on a year-over-year basis. Equities research analysts anticipate that NICE Ltd. will post 9.85 EPS for the current year.
About NICE
(
Free Report)
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NICE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NICE wasn't on the list.
While NICE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
